TrialClinical and translational science2024

Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants.

Anees M Dauki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.